FDA OK’s Pfizer booster shots for kids ages 5-11

FOX NEWS — The U.S. Food and Drug Administration (FDA) announced Tuesday that it had amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine, allowing the use of a single booster dose in children ages 5 to 11.

The shot would be given at least five months after completion of a primary series with the Pfizer-BioNTech vaccine.

“The FDA is authorizing the use of a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for children 5 through 11 years of age to provide continued protection against COVID-19,” FDA Commissioner Dr. Robert Califf said in a statement.”